Terms: = Sarcomas AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Prognosis
19 results:
1. High-Grade Spindle Cell Sarcoma of the Scalp With an MGA::NUTM1 Gene Fusion in a Pediatric Patient.
Arellano Zameza P; Karklins SP; Pena J; Bowers NL; Samman A; Ahn C; Sangueza OP
Am J Dermatopathol; 2024 Feb; 46(2):101-103. PubMed ID: 38055974
[TBL] [Abstract] [Full Text] [Related]
2. Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
Chen AP; Sharon E; O'Sullivan-Coyne G; Moore N; Foster JC; Hu JS; Van Tine BA; Conley AP; Read WL; Riedel RF; Burgess MA; Glod J; Davis EJ; Merriam P; Naqash AR; Fino KK; Miller BL; Wilsker DF; Begum A; Ferry-Galow KV; Deshpande HA; Schwartz GK; Ladle BH; Okuno SH; Beck JC; Chen JL; Takebe N; Fogli LK; Rosenberger CL; Parchment RE; Doroshow JH
N Engl J Med; 2023 Sep; 389(10):911-921. PubMed ID: 37672694
[TBL] [Abstract] [Full Text] [Related]
3. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract] [Full Text] [Related]
4. The expanding universe of NUTM1 fusions in pediatric cancer.
Charlab R; Racz R
Clin Transl Sci; 2023 Aug; 16(8):1331-1339. PubMed ID: 37082775
[TBL] [Abstract] [Full Text] [Related]
5. Oncolytic strategy using new bifunctional HDACs/brd4 inhibitors against virus-associated lymphomas.
Chen J; Wang Z; Phuc T; Xu Z; Yang D; Chen Z; Lin Z; Kendrick S; Dai L; Li HY; Qin Z
PLoS Pathog; 2023 Jan; 19(1):e1011089. PubMed ID: 36638143
[TBL] [Abstract] [Full Text] [Related]
6. Report of the First International Symposium on NUT Carcinoma.
French CA; Cheng ML; Hanna GJ; DuBois SG; Chau NG; Hann CL; Storck S; Salgia R; Trucco M; Tseng J; Stathis A; Piekarz R; Lauer UM; Massard C; Bennett K; Coker S; Tontsch-Grunt U; Sos ML; Liao S; Wu CJ; Polyak K; Piha-Paul SA; Shapiro GI
Clin Cancer Res; 2022 Jun; 28(12):2493-2505. PubMed ID: 35417004
[TBL] [Abstract] [Full Text] [Related]
7. Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment.
Marchesi I; Fais M; Fiorentino FP; Bordoni V; Sanna L; Zoroddu S; Bagella L
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408939
[TBL] [Abstract] [Full Text] [Related]
8. Augmented Antitumor Activity for Novel Dual PI3K/BDR4 Inhibitors, SF2523 and SF1126 in Ewing Sarcoma.
Goldin AN; Singh A; Joshi S; Jamieson C; Durden DL
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e304-e311. PubMed ID: 33480647
[TBL] [Abstract] [Full Text] [Related]
9. Cold Atmospheric Plasma Treatment of Chondrosarcoma Cells Affects Proliferation and Cell Membrane Permeability.
Haralambiev L; Nitsch A; Jacoby JM; Strakeljahn S; Bekeschus S; Mustea A; Ekkernkamp A; Stope MB
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225067
[TBL] [Abstract] [Full Text] [Related]
10. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.
Guo CM; Liu SQ; Sun MZ
Neoplasma; 2020 Mar; 67(2):215-228. PubMed ID: 31884798
[TBL] [Abstract] [Full Text] [Related]
11. brd4 promotes tumor progression and NF-κB/CCL2-dependent tumor-associated macrophage recruitment in GIST.
Mu J; Sun P; Ma Z; Sun P
Cell Death Dis; 2019 Dec; 10(12):935. PubMed ID: 31819043
[TBL] [Abstract] [Full Text] [Related]
12. HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy.
Rottmann D; Snir OL; Wu X; Wong S; Hui P; Santin AD; Buza N
Mod Pathol; 2020 Jan; 33(1):118-127. PubMed ID: 31477811
[TBL] [Abstract] [Full Text] [Related]
13. Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma.
Tornin J; Mateu-Sanz M; Rodríguez A; Labay C; Rodríguez R; Canal C
Sci Rep; 2019 Jul; 9(1):10681. PubMed ID: 31337843
[TBL] [Abstract] [Full Text] [Related]
14. EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins.
Gollavilli PN; Pawar A; Wilder-Romans K; Natesan R; Engelke CG; Dommeti VL; Krishnamurthy PM; Nallasivam A; Apel IJ; Xu T; Qin ZS; Feng FY; Asangani IA
Cancer Res; 2018 Aug; 78(16):4760-4773. PubMed ID: 29898995
[TBL] [Abstract] [Full Text] [Related]
15. [Grading of soft tissue and bone sarcomas].
Petersen I; Wardelmann E
Pathologe; 2016 Jul; 37(4):320-7. PubMed ID: 27384333
[TBL] [Abstract] [Full Text] [Related]
16. [Analysis of the diagnosis and treatment of desmoplastic small round cell tumor].
Lu B; Zhang W; Shang Z; Sun E; Nian X; Gao J; Ma C; Han R
Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):686-90. PubMed ID: 26813434
[TBL] [Abstract] [Full Text] [Related]
17. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with brd4 inhibitors.
Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
[TBL] [Abstract] [Full Text] [Related]
18. Secondary chondrosarcoma.
Lin PP; Moussallem CD; Deavers MT
J Am Acad Orthop Surg; 2010 Oct; 18(10):608-15. PubMed ID: 20889950
[TBL] [Abstract] [Full Text] [Related]
19. Bone morphogenetic proteins in bone tumors.
Yoshikawa H; Nakase T; Myoui A; Ueda T
J Orthop Sci; 2004; 9(3):334-40. PubMed ID: 15168194
[TBL] [Abstract] [Full Text] [Related]